Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05531461 · ClinicalTrials.gov registry record
Cognition and Imaging With Tigertriever
A clinical trial of Stroke, sponsored by Rapid Medical.
- Recruiting
- Registry status
- 424
- Enrollment target
- 3
- Study locations
NCT05531461: Recruiting study of Stroke, sponsored by Rapid Medical.
NCT05531461 is a study of Stroke that is actively recruiting participants, run by Rapid Medical. The registered enrollment target is 424 participants, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05531461, a study of Stroke, is actively recruiting participants, sponsored by Rapid Medical.
- RECRUITING
- Registry status
- 424 participants
- Enrollment target
- 3
- Study locations
Study Summary
The objective of the COGNITIVE Study is to evaluate whether successful reperfusion with Tigertriever is associated with cognitive benefit.
Conditions Studied
Study Locations (3)
California
- University of California - Los Angeles
Michigan
- Corewell Health Research Institute - Grand Rapids
New York
- Westchester Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 424 participants |
| Start Date | 2024-10-28 |
| Est. Completion | 2026-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05531461
The ClinicalTrials.gov registry entry for NCT05531461 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 424 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (96% lower). The listed sponsor is Rapid Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 0 interventions.
NCT05531461 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Michigan, New York.
Frequently Asked Questions
What is clinical trial NCT05531461 about?
NCT05531461 is a clinical study titled "Cognition and Imaging With Tigertriever". The objective of the COGNITIVE Study is to evaluate whether successful reperfusion with Tigertriever is associated with cognitive benefit.
What is the current status of trial NCT05531461?
This trial is currently recruiting. The enrollment target is 424 participants. The study started on 2024-10-28. Estimated completion is 2026-11.
What conditions does trial NCT05531461 study?
This clinical trial studies the following conditions: Stroke.
Who is sponsoring clinical trial NCT05531461?
This trial is sponsored by Rapid Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05531461 being conducted?
This trial has 3 study locations across California, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.